Weatherstone Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Weatherstone Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-7,312	Closed	-$394K	–	103
2016 Q3	$394K	Sell	7,312 -7	-0.1%	-$450	0.32%	39
2016 Q2	$538K	Buy	7,319 +88	+1%	+$6.22K	0.46%	28
2016 Q1	$462K	Sell	7,231 -86	-1%	-$5.42K	0.33%	37
2015 Q4	$503K	Sell	7,317 -29	-0.4%	-$1.92K	0.58%	37
2015 Q3	$435K	Sell	7,346 -421	-5%	-$26.7K	0.4%	32
2015 Q2	$517K	Buy	7,767 +186	+2%	+$12.3K	0.46%	38
2015 Q1	$509K	Buy	7,581 +868	+13%	+$54.3K	0.31%	41
2014 Q4	$396K	Buy	6,713 +1,070	+19%	+$60.3K	0.23%	43
2014 Q3	$292K	Buy	5,643 +15	+0.3%	+$749	0.15%	40
2014 Q2	$273K	Hold	5,628	–	–	0.07%	59
2014 Q1	$292K	Hold	5,628	–	–	0.09%	44
2013 Q4	$301K	Hold	5,628	–	–	0.07%	52
2013 Q3	$260K	Hold	5,628	–	–	0.07%	43
2013 Q2	$261K	Buy	+5,628	New	+$244K	0.11%	42

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Weatherstone Capital Management's BMY Position: Q4 2016 in Review

Weatherstone Capital Management sold out of Bristol-Myers Squibb (BMY) in Q4 2016, closing a stake of 7,312 shares — an estimated $394K sold.

Weatherstone Capital Management first reported a position in BMY in Q2 2013 and held it in 14 quarters. The position peaked at $538K in Q2 2016. 1,601 funds tracked by Wall St. Rank hold BMY as of Q4 2016.

Weatherstone Capital Management reported no remaining Bristol-Myers Squibb position as of Q4 2016 after selling out during the quarter.
Weatherstone Capital Management sold 7,312 Bristol-Myers Squibb shares in Q4 2016, an estimated $394K.
Weatherstone Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 14 quarters.
Weatherstone Capital Management's Bristol-Myers Squibb position peaked at $538K in Q2 2016.
1,601 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2016.

Based on Weatherstone Capital Management's 13F filing for Q4 2016, filed 13 Feb 2017.